Single cell transcriptomes of cell cultures differentiated from human pluripotent stem cells (hPSCs) following the HX protocol (Xi et al., Cell Rep, 2017) for 6 weeks. Cells are either non-enriched or enriched using an endogenous PAX7-driven GFP reporter.
Single cell transcriptomes of the skeletal muscle (SkM) lineage from human pluripotent stem cell (hPSCs) differentiated for 5 weeks using the HX protocol (Xi et al., Cell Rep, 2017). Cells are subjected to re-clustering to reveal potential heterogeneity within the myogenic subset.
Single cell transcriptomes of cell cultures differentiated from human pluripotent stem cells (hPSCs) following the HX protocol (Xi et al., Cell Rep, 2017) for 5 weeks. Cells are either non-enriched, or enriched using an endogenous PAX7-driven GFP reporter or cell surface marker combination of ERBB3+NGFR+HNK1-.
Single cell transcriptomes of the skeletal muscle (SkM) lineage from human pluripotent stem cell (hPSCs) differentiated for 4 weeks using the HX protocol (Xi et al., Cell Rep, 2017). Cells are subjected to re-clustering to reveal potential heterogeneity within the myogenic subset.
Single cell transcriptomes of cell cultures differentiated from human pluripotent stem cells (hPSCs) following the HX protocol (Xi et al., Cell Rep, 2017) for 4 weeks. Cells are either non-enriched or enriched using an endogenous PAX7-driven GFP reporter.
Single cell transcriptomes of cell cultures differentiated from human pluripotent stem cells (hPSCs) following the HX protocol (Xi et al., Cell Rep, 2017) for 3 weeks. Cells are either non-enriched or enriched using an endogenous PAX7-driven GFP reporter.
Single cell transcriptomes of the skeletal muscle (SkM) lineage from the quadriceps muscles of human adults. Cells are subjected to re-clustering to reveal potential heterogeneity within the myogenic subset. Two independent biological samples at 34 and 42 years old are included.
Single cell transcriptomes of the quadriceps muscles from human adults. Hematopoietic and endothelial cells are pre-excluded by FACS. Two independent biological samples at 34 and 42 years old are included.
Single cell transcriptomes of the skeletal muscle (SkM) lineage from hindlimbs of 12-14 week human fetuses. Cells are subjected to re-clustering to reveal potential heterogeneity within the myogenic subset. Two independent biological samples are included.
Single cell transcriptomes of the total skeletal muscle tissues of hindlimbs from human fetuses of 12-14 weeks of development. Hematopoietic and endothelial cells are pre-excluded by FACS. Two independent biological samples are included.